oxycodone and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted

oxycodone has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's5 (62.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Collins, M; Conway, B; Dylla, DE; Khan, T; Marcinak, J; Martinez, A; Saget, B1
Beheshti, D1
Alpert, A; Pacula, RL; Powell, D2
Bigal, ME1
Havens, JR; Stephens, DB1
Okon, T1
Lake, JR; Lucey, MR1

Reviews

2 review(s) available for oxycodone and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted

ArticleYear
Abuse-Deterrent OxyContin And Hepatitis C.
    Health affairs (Project Hope), 2019, Volume: 38, Issue:4

    Topics: Adult; Antiviral Agents; Disease Progression; Female; Follow-Up Studies; Hepacivirus; Hepatitis C; Humans; Opioid-Related Disorders; Oxycodone; Risk Assessment; Severity of Illness Index; Substance-Related Disorders

2019
Ketamine: an introduction for the pain and palliative medicine physician.
    Pain physician, 2007, Volume: 10, Issue:3

    Topics: Adult; Amines; Analgesics; Analgesics, Opioid; Central Nervous System; Cryoglobulinemia; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Female; Gabapentin; gamma-Aminobutyric Acid; Hepatitis C; Humans; Ketamine; Methadone; Methylphenidate; Oxycodone; Pain, Intractable; Receptors, N-Methyl-D-Aspartate; Treatment Outcome; Ulcer; Vasculitis

2007

Other Studies

6 other study(ies) available for oxycodone and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted

ArticleYear
Reported adverse events related to use of hepatitis C virus direct-acting antivirals with opioids: 2017-2021.
    Harm reduction journal, 2023, 10-01, Volume: 20, Issue:1

    Topics: Analgesics, Opioid; Antiviral Agents; Fentanyl; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Hydrocodone; Oxycodone; Sofosbuvir

2023
Adverse health effects of abuse-deterrent opioids: Evidence from the reformulation of OxyContin.
    Health economics, 2019, Volume: 28, Issue:12

    Topics: Analgesics, Opioid; Drug Administration Routes; Drug Overdose; Hepatitis A; Hepatitis B; Hepatitis C; Heroin; HIV Infections; Humans; Opioid-Related Disorders; Oxycodone; Prescription Drug Misuse; Substance Abuse, Intravenous; Technology, Pharmaceutical; United States

2019
A Transitioning Epidemic: How The Opioid Crisis Is Driving The Rise In Hepatitis C.
    Health affairs (Project Hope), 2019, Volume: 38, Issue:2

    Topics: Analgesics, Opioid; Hepacivirus; Hepatitis C; Humans; Illicit Drugs; Injections, Intravenous; Opioid Epidemic; Opioid-Related Disorders; Oxycodone; Prescription Drug Misuse; United States

2019
Abuse-Deterrent Opioids: The Authors Reply.
    Health affairs (Project Hope), 2019, Volume: 38, Issue:4

    Topics: Analgesics, Opioid; Chronic Pain; Hepatitis C; Humans; Opioid-Related Disorders; Oxycodone

2019
Predictors of alcohol use among rural drug users after disclosure of hepatitis C virus status.
    Journal of studies on alcohol and drugs, 2013, Volume: 74, Issue:3

    Topics: Adult; Alcohol Drinking; Appalachian Region; Counseling; Disclosure; Female; Follow-Up Studies; Hepatitis C; Humans; Longitudinal Studies; Male; Marijuana Abuse; Multivariate Analysis; Oxycodone; Prospective Studies; Regression Analysis; Rural Population; Substance-Related Disorders; Surveys and Questionnaires

2013
The challenging patient: HCV and alcoholic liver disease.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2007, Volume: 13, Issue:11 Suppl 2

    Topics: Back Pain; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Inflammation; Lactulose; Liver; Liver Diseases, Alcoholic; Liver Transplantation; Male; Middle Aged; Oxycodone

2007